XML 81 R71.htm IDEA: XBRL DOCUMENT v3.22.2
Investments in Unconsolidated Entities (Summarized Financial Information Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2021
Mar. 31, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Schedule of Equity Method Investments [Line Items]              
Net income (loss) attributable to common stockholders $ (64,881,000)   $ 32,655,000   $ (74,783,000) $ 70,511,000  
Other assets [1] 6,281,000       6,281,000   $ 3,710,000
Liabilities 4,944,422,000       4,944,422,000   3,853,863,000
Stockholders' Equity Attributable to Parent 1,208,149,000       1,208,149,000   1,291,321,000
Total Liabilities and Equity 6,178,877,000       6,178,877,000   5,177,419,000
Equity Method Investment, Summarized Financial Information [Abstract]              
Total Assets 6,178,877,000       6,178,877,000   5,177,419,000
Interest income 62,722,000   45,890,000   113,796,000 85,970,000  
Interest expense (26,024,000)   (11,166,000)   (40,041,000) (22,508,000)  
Interest Income (Expense), Net 36,698,000   34,724,000   73,755,000 63,462,000  
Noninterest Income (69,607,000)   5,708,000 [2]   (95,049,000) 25,937,000 [2]  
Operating Expenses 13,102,000   19,425,000   32,669,000 31,754,000  
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest (61,451,000) $ (6,498,000) 36,469,000 $ 41,256,000 (67,949,000) 77,725,000  
Income Tax Expense (Benefit) (7,825,000)   3,140,000   (14,785,000) 5,157,000  
Other, net (166,000)   2,166,000 [2]   1,054,000 2,946,000 [2]  
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest (46,011,000)   21,007,000   (53,963,000) 57,645,000  
Earnings (losses) from investments in unconsolidated entities (23,265,000)   18,602,000   (28,771,000) 25,237,000  
Investment in unconsolidated entities, at fair value [1] 192,269,000       192,269,000   195,643,000
Investment in Loan Originator              
Equity Method Investment, Summarized Financial Information [Abstract]              
Investment in unconsolidated entities, at fair value 111,400,000       111,400,000   137,800,000
LendSure Mortgage Corp [Member]              
Equity Method Investment, Summarized Financial Information [Abstract]              
Earnings (losses) from investments in unconsolidated entities (7,700,000)   3,200,000   (12,100,000) 5,600,000  
LendSure Mortgage Corp [Member] | Investment in Loan Originator              
Equity Method Investment, Summarized Financial Information [Abstract]              
Investment in unconsolidated entities, at fair value 33,400,000       33,400,000   45,500,000
LendSure Mortgage Corp [Member] | Significant non-consolidated entity              
Schedule of Equity Method Investments [Line Items]              
Revenues 14,457,000   19,048,000   30,019,000 31,412,000  
Net income (loss) attributable to common stockholders 756,000   6,747,000   1,154,000 10,377,000  
Longbridge Financial LLC [Member]              
Equity Method Investment, Summarized Financial Information [Abstract]              
Earnings (losses) from investments in unconsolidated entities (13,700,000)   10,800,000   (16,900,000) 11,300,000  
Longbridge Financial LLC [Member] | Investment in Loan Originator              
Equity Method Investment, Summarized Financial Information [Abstract]              
Investment in unconsolidated entities, at fair value 59,100,000       59,100,000   $ 74,500,000
Longbridge Financial LLC [Member] | Significant non-consolidated entity              
Schedule of Equity Method Investments [Line Items]              
Revenues (73,766,000)   61,700,000   (131,507,000) 100,236,000  
Net income (loss) attributable to common stockholders $ (24,014,000)   $ 19,186,000   $ (34,665,000) $ 31,712,000  
[1] Ellington Financial Inc.'s Condensed Consolidated Balance Sheet includes assets and liabilities of variable interest entities it has consolidated. See Note 9 for additional details on Ellington Financial Inc.'s consolidated variable interest entities.
[2] Conformed to current period presentation.